Granite Investment Partners LLC lowered its stake in shares of icad inc. (NASDAQ:ICAD) by 4.6% during the second quarter, Holdings Channel reports. The fund owned 346,066 shares of the technology company’s stock after selling 16,838 shares during the period. Granite Investment Partners LLC’s holdings in icad inc. were worth $1,450,000 at the end of the most recent quarter.

Separately, Essex Investment Management Co. LLC raised its stake in icad inc. by 822.3% in the second quarter. Essex Investment Management Co. LLC now owns 139,766 shares of the technology company’s stock valued at $586,000 after buying an additional 124,612 shares during the last quarter. 25.26% of the stock is owned by institutional investors.

icad inc. (NASDAQ ICAD) opened at 3.71 on Friday. icad inc. has a one year low of $2.82 and a one year high of $6.49. The stock’s 50 day moving average is $3.98 and its 200 day moving average is $4.35. The firm’s market cap is $60.75 million.

icad inc. (NASDAQ:ICAD) last released its quarterly earnings data on Tuesday, August 8th. The technology company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.03. icad inc. had a negative return on equity of 44.39% and a negative net margin of 34.74%. The firm had revenue of $6.41 million during the quarter, compared to analyst estimates of $6.41 million. On average, equities research analysts expect that icad inc. will post ($0.49) earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Granite Investment Partners LLC Sells 16,838 Shares of icad inc. (NASDAQ:ICAD)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/13/granite-investment-partners-llc-sells-16838-shares-of-icad-inc-nasdaqicad.html.

Separately, Laidlaw reissued a “buy” rating and set a $11.00 price target on shares of icad inc. in a report on Tuesday, July 25th.

icad inc. Company Profile

iCAD, Inc is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy).

Want to see what other hedge funds are holding ICAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for icad inc. (NASDAQ:ICAD).

Institutional Ownership by Quarter for icad inc. (NASDAQ:ICAD)

Receive News & Ratings for icad inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for icad inc. and related companies with MarketBeat.com's FREE daily email newsletter.